NCT06357169

Brief Summary

The objective of this study is to assess the effect of standardized scalp care, specifically mechanical cleansing with the Venus Glow™ Device and water, on the scalp microbiome. This study also seeks to characterize the microbiome of the normal, healthy scalp, thereby providing a baseline for which the scalp affected by hair and scalp disease can be compared.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
23

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Jan 2023

Geographic Reach
1 country

1 active site

Status
terminated

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 13, 2023

Completed
2 months until next milestone

First Submitted

Initial submission to the registry

February 27, 2023

Completed
4 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 30, 2023

Completed
7 months until next milestone

Study Completion

Last participant's last visit for all outcomes

January 13, 2024

Completed
3 months until next milestone

First Posted

Study publicly available on registry

April 10, 2024

Completed
10 months until next milestone

Results Posted

Study results publicly available

February 12, 2025

Completed
Last Updated

February 12, 2025

Status Verified

January 1, 2025

Enrollment Period

6 months

First QC Date

February 27, 2023

Results QC Date

October 24, 2024

Last Update Submit

January 21, 2025

Conditions

Outcome Measures

Primary Outcomes (1)

  • Scalp Microbiome Composition

    as assessed by relative abundance of genera from scalp swab DNA extraction of the right and left mid-frontal scalp. Kruskal-Wallis will be used to assess variation in microbiome composition between treatment groups

    Day 14

Secondary Outcomes (3)

  • Scalp Health

    Assessed at day 1 (baseline).

  • Post-treatment 1 Right-sided Scalp Health

    Assessed at day 7

  • Post-treatment 2 Right-sided Scalp Health

    Assessed at day 14

Study Arms (1)

Healthy-experimental

EXPERIMENTAL

Healthy participants who have not been diagnosed with scalp or hair disease will be followed over a period of 2 weeks to assess their scalp microbiome and see how well the investigational device works on decreasing the microbe burden of the scalp.

Device: Venus Glow

Interventions

two treatments over a one week period. At the first visit they will complete an initial questionnaire regarding current scalp care practices, skin type, and hair type. An initial baseline scalp swab and HairMetrix photography in the two swab sites will be taken at the beginning of this visit. Treatment with the Venus Glow™ device will also occur. To treat, the scalp will be divided into four quadrants. Swab samples will be collected at the first baseline and concurrent treatment session, second treatment session and 3-6 days after the last treatment when participants have returned to their usual cleansing routine.

Healthy-experimental

Eligibility Criteria

Age18 Years - 35 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • All individuals between 18-35 years of age
  • Ability to understand study procedures and to comply with them

You may not qualify if:

  • Non-English speakers
  • Current scalp or hair disease diagnosis
  • Using oral or topical antimicrobial medication 4 weeks prior to their baseline visit or in the duration of the study
  • Current clinical condition that, in the opinion of the site investigator, would interfere with adherence to study requirements
  • Inability or unwillingness of individual to give written informed consent

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Minnesota

Minneapolis, Minnesota, 55455, United States

Location

MeSH Terms

Conditions

Alopecia Areata

Condition Hierarchy (Ancestors)

AlopeciaHypotrichosisHair DiseasesSkin DiseasesSkin and Connective Tissue Diseases

Limitations and Caveats

The limitations of the trial are as follows: small sample size, short interim between treatment sessions, no scalp/hair disease group.

Results Point of Contact

Title
Ronda Farah
Organization
University of Minnesota

Study Officials

  • Ronda Farah, MD

    University of Minnesota

    PRINCIPAL INVESTIGATOR
  • Maria Hordinsky, MD

    University of Minnesota

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
Yes

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
SUPPORTIVE CARE
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

February 27, 2023

First Posted

April 10, 2024

Study Start

January 13, 2023

Primary Completion

June 30, 2023

Study Completion

January 13, 2024

Last Updated

February 12, 2025

Results First Posted

February 12, 2025

Record last verified: 2025-01

Locations